Gene · 5598
Papers3,971
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,971
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Suppression of the KRAS-NRF2 axis shifts arginine into the phosphocreatine energy system in pancreatic cancer cells. | iScience | 2023 | 38144458 | PubTator, text mining | PubMed |
| Mir-142-3P regulates MAPK protein family by inhibiting 14-3-3η to enhance bone marrow mesenchymal stem cells osteogenesis. | Sci Rep | 2023 | 38129425 | PubTator, text mining | PubMed |
| Retracted: Effects of the Wenyang Zhenshuai Granule on the Expression of LncRNA-MiR143HG/miR-143 Regulating ERK5 in H9C2 Cardiomyocytes. | Evid Based Complement Alternat Med | 2023 | 38125184 | PubTator, text mining | PubMed |
| Knowledge mapping of idiopathic scoliosis genes and research hotspots (2002-2022): a bibliometric analysis. | Front Pediatr | 2023 | 38111628 | PubTator, text mining | PubMed |
| Mechanisms Behind the Pharmacological Application of Biochanin-A: A review. | F1000Res | 2023 | 38106650 | PubTator, text mining | PubMed |
| Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies. | Signal Transduct Target Ther | 2023 | 38105263 | PubTator, text mining | PubMed |
| Targeting ST8SIA6-AS1 counteracts KRASG12C inhibitor resistance through abolishing the reciprocal activation of PLK1/c-Myc signaling. | Exp Hematol Oncol | 2023 | 38104151 | PubTator, text mining | PubMed |
| Role of the P2 × 7 receptor in neurodegenerative diseases and its pharmacological properties. | Cell Biosci | 2023 | 38093352 | PubTator, text mining | PubMed |
| Research progress on the mechanism of glycolysis in ovarian cancer. | Front Immunol | 2023 | 38090580 | PubTator, text mining | PubMed |
| Research progress of ginger in the treatment of gastrointestinal tumors. | World J Gastrointest Oncol | 2023 | 38077642 | PubTator, text mining | PubMed |
| CTSK and PLAU as Prognostic Biomarker and Related to Immune Infiltration in Pancreatic Cancer: Evidence from Bioinformatics Analysis and qPCR. | Int J Genomics | 2023 | 38077303 | PubTator, text mining | PubMed |
| Double-edged role of mechanical stimuli and underlying mechanisms in cartilage tissue engineering. | Front Bioeng Biotechnol | 2023 | 38053849 | PubTator, text mining | PubMed |
| Identification of FtfL as a novel target of berberine in intestinal bacteria. | BMC Biol | 2023 | 38049785 | PubTator, text mining | PubMed |
| The doublecortin-family kinase ZYG-8DCLK1 regulates motor activity to achieve proper force balance in C. elegans acentrosomal spindles. | bioRxiv | 2023 | 38045228 | PubTator, text mining | PubMed |
| Activation of the Nrf-2/HO-1 signalling axis can alleviate metabolic syndrome in cardiovascular disease. | Ann Med | 2023 | 38039549 | PubTator, text mining | PubMed |
| A guide to ERK dynamics, part 1: mechanisms and models. | Biochem J | 2023 | 38038974 | PubTator, text mining | PubMed |
| Exploring lncRNAs associated with human pancreatic islet cell death induced by transfer of adoptive lymphocytes in a humanized mouse model. | Front Endocrinol (Lausanne) | 2023 | 38027148 | PubTator, text mining | PubMed |
| Histone deacetylase inhibitor pracinostat suppresses colorectal cancer by inducing CDK5-Drp1 signaling-mediated peripheral mitofission. | J Pharm Anal | 2023 | 38024857 | PubTator, text mining | PubMed |
| Targeting Neutrophil Extracellular Traps: A Novel Antitumor Strategy. | J Immunol Res | 2023 | 38023616 | PubTator, text mining | PubMed |
| Contribution of m5C RNA Modification-Related Genes to Prognosis and Immunotherapy Prediction in Patients with Ovarian Cancer. | Mediators Inflamm | 2023 | 38022687 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5598/papers?page=11